Literature DB >> 31792601

Abdominal obesity increases risk for esophageal cancer: a nationwide population-based cohort study of South Korea.

Jae Ho Cho1, Cheol Min Shin1, Kyung-Do Han2, Hyuk Yoon1, Young Soo Park1, Nayoung Kim1, Dong Ho Lee3.   

Abstract

BACKGROUND: The relationship between overall obesity, as measured by body mass index (BMI) and risk of esophageal squamous cell carcinoma (ESCC) has been reported to show a negative correlation. However, the relationship of ESCC, which accounts for around 90% of esophageal cancers in South Korea, with abdominal obesity, as measured by waist circumference (WC), may be different. Thus, we investigated the association between abdominal obesity and esophageal cancer in a nationwide population-based cohort.
METHODS: A retrospective cohort study of 22,809,722 individuals who had undergone regular health check-ups provided by the National Health Insurance Corporation between 2009 and 2012 (median follow-up period, 6.4 years) in South Korea was conducted. Abdominal obesity was defined as a WC > 90 cm for men and > 85 cm for women. We estimated hazard ratios (HRs) and 95% confidence intervals (CIs) using χ2 test and Cox proportional hazards model adjusted for confounding factors. The primary outcome was newly developed esophageal cancer.
RESULTS: After adjusting for BMI, abdominal obesity increased the risk of esophageal cancer (HR 1.29, 95% CI 1.23-1.36). WC increased the risk for esophageal cancer in a dose-dependent manner (p values for trend < 0.0001). Among overweight (BMI 23-24.9 kg/m2) and obese I (BMI 25-29.9 kg/m2) individuals, abdominal obesity was a risk factor for esophageal cancer (HR 1.22, 95% CI 1.11-1.34; HR 1.28, 95% CI 1.18-1.39, respectively).
CONCLUSION: Increasing abdominal obesity may be associated with an increased risk for esophageal cancer. Further studies are warranted to confirm the relationship.

Entities:  

Keywords:  Abdominal obesity; Esophageal cancer; Esophageal squamous cell carcinoma; Waist circumference

Mesh:

Year:  2019        PMID: 31792601     DOI: 10.1007/s00535-019-01648-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  42 in total

1.  Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea.

Authors:  Juneyoung Lee; Ji Sung Lee; Sook-Hee Park; Soon Ae Shin; KeeWhan Kim
Journal:  Int J Epidemiol       Date:  2017-04-01       Impact factor: 7.196

2.  Adipocytokines and squamous cell carcinoma of the esophagus.

Authors:  Takako Eguchi Nakajima; Yasuhide Yamada; Tetsutaro Hamano; Koh Furuta; Ichiro Oda; Hoichi Kato; Ken Kato; Tetsuya Hamaguchi; Yasuhiro Shimada
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-20       Impact factor: 4.553

3.  Height and body mass index in relation to esophageal cancer; 23-year follow-up of two million Norwegian men and women.

Authors:  Anders Engeland; Steinar Tretli; Tone Bjørge
Journal:  Cancer Causes Control       Date:  2004-10       Impact factor: 2.506

Review 4.  Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity.

Authors:  Michio Hongo; Yutaka Nagasaki; Tomotaka Shoji
Journal:  J Gastroenterol Hepatol       Date:  2009-05       Impact factor: 4.029

5.  Abdominal obesity and the risk of esophageal and gastric cardia carcinomas.

Authors:  Douglas A Corley; Ai Kubo; Wei Zhao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02       Impact factor: 4.254

6.  Effect of obesity on esophageal transit.

Authors:  C D Mercer; C Rue; L Hanelin; L D Hill
Journal:  Am J Surg       Date:  1985-01       Impact factor: 2.565

7.  Joint Effects of Low Body Mass Index and Alcohol Consumption on Developing Esophageal Squamous Cell Cancer: a Korean Nationwide Population-Based Cohort Study

Authors:  Yoon Jin Choi; Dong Ho Lee; Kyung Do Han; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim
Journal:  Asian Pac J Cancer Prev       Date:  2017-07-27

Review 8.  Abdominal obesity and gastroesophageal cancer risk: systematic review and meta-analysis of prospective studies.

Authors:  Xuan Du; Khemayanto Hidayat; Bi-Min Shi
Journal:  Biosci Rep       Date:  2017-05-11       Impact factor: 3.840

9.  Elevated serum gamma-glutamyltransferase is associated with an increased risk of oesophageal carcinoma in a cohort of 8,388,256 Korean subjects.

Authors:  Yoon Jin Choi; Dong Ho Lee; Kyung-Do Han; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

10.  The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea.

Authors:  Yoon Jin Choi; Dong Ho Lee; Kyung-Do Han; Hyun Soo Kim; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

View more
  7 in total

1.  Intracellular Nampt impairs esophageal squamous cell carcinoma neo-adjuvant chemotherapy response independent of eNampt.

Authors:  Jiahuang Liu; Xiangming Che; Jiangtao You; Guangjian Zhang; Rui Zhao; Junke Fu; Haijun Li
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  Lipid metabolism-related lncRNA SLC25A21-AS1 promotes the progression of oesophageal squamous cell carcinoma by regulating the NPM1/c-Myc axis and SLC25A21 expression.

Authors:  Yu Liu; Chunxiang Li; Lingling Fang; Liyu Wang; Hengchang Liu; He Tian; Yujia Zheng; Tao Fan; Jie He
Journal:  Clin Transl Med       Date:  2022-06

3.  Obesity and incident gastrointestinal cancers: overall body size or central obesity measures, which factor matters?

Authors:  Nahid Hashemi Madani; Arash Etemadi; Mahdi Nalini; Hossein Poustchi; Alireza Khajavi; Elahe Mirzazade; Hosna Mirfakhraei; Akram Pourshams; Masoud Khoshnia; Abdolsamad Gharavi; Shahin Merat; Moahammad E Khamseh; Reza Malekzadeh
Journal:  Eur J Cancer Prev       Date:  2021-05-01       Impact factor: 2.164

4.  Chinese and Global Burdens of Gastrointestinal Cancers From 1990 to 2019.

Authors:  Wangcheng Xie; Tingsong Yang; Jieliang Zuo; Zhilong Ma; Weidi Yu; Zhengyu Hu; Zhenshun Song
Journal:  Front Public Health       Date:  2022-07-13

5.  Cost-effectiveness analysis of nivolumab combination therapy in the first-line treatment for advanced esophageal squamous-cell carcinoma.

Authors:  Shixian Liu; Lei Dou; Kaixuan Wang; Zhao Shi; Ruixue Wang; Xiaohong Zhu; Zehua Song; Shunping Li
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

6.  Nonalcoholic fatty liver disease is associated with the development of obstructive sleep apnea.

Authors:  Goh Eun Chung; Eun Ju Cho; Kyungdo Han; Su Jong Yu; Jeong-Ju Yoo; Young Chang; Yuri Cho; Sang-Hyun Park; Dong Wook Shin
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

7.  Association of Metabolic Parameter Variability with Esophageal Cancer Risk: A Nationwide Population-Based Study.

Authors:  Ji Eun Lee; Kyungdo Han; Juhwan Yoo; Yohwan Yeo; In Young Cho; Belong Cho; Hyuktae Kwon; Dong Wook Shin; Jong Ho Cho; Yong-Moon Park
Journal:  J Pers Med       Date:  2022-03-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.